Advanced Filters
noise
Found 64,778 clinical trials
T Tatiana Djikeussi

Safety and Effectiveness of PANAF-Premium TM Snake Venom Antiserum As Standard Treatment for Snakebites

Snakebite envenomation (SBE) is a major public health problem in many developing countries. Standard snake antivenom (SA) remains the primary treatment and has been shown to reduce mortality in observational studies conducted in several sub-Saharan African (SSA) countries. Although it is relatively available in other endemic contexts such as Asia …

years of age All Phase N/A
G Guangyou Duan, MD

Circadian Rhythm Status and CS (Cesarean Section) Postoperative Pain

Use huawei wristwatch to record maternal rhythm status and record the VAS score after cesarean section under combined spinal-epidural anesthesia. Based on this study the investigators intend to explore the correlation between maternal circadian rhythm status and postoperative pain after cesarean section.

20 - 45 years of age Female Phase N/A
A Alex Tan Weixian, MBBS

Using Laser Spatiotemporal Photoplethysmogram and Computational Method for Management of Chronic Disorders.

This investigational study is carried out to find out if a smartwatch monitor worn on the wrist that acts like a blood pressure monitor, will be able to replace the traditional blood pressure measurements using the traditional cuff that is wrapped around your arm.

21 years of age All Phase N/A
Y Yohan DESBROSSES, Dr

Results From a French Temporary Utilization Authorization of First-line Acute Myeloid Leukemia (AML) Patients Ineligible for Intensive Chemotherapy (IC), Treated With Venetoclax Azacitidine

Following the results of the phase 1b and the phase 3 studies, Venetoclax/Azacitidine (VEN/AZA) was available in France for newly diagnosed AML patients ineligible-IC patients through the early access program the so-called ATU program. Venetoclax (VEN) has been available in France through the ATU since Feb 2021 and through the …

18 years of age All Phase N/A
y yuhao shao, MD

The Impact of Soft Contact Lenses on the Corneal Neuromediators and Optical Quality in High Myopia Prior to SMILE

To investigate the influence of Neuromediators expression in corneal stromal lenticules and corneal injury repair after small incision extraction

18 - 45 years of age All Phase N/A

Interest in Combining Intraoperative ElectroEncephaloGram (EEG) With Assessment of Frailty to Predict Postoperative Delirium in Patients Aged >75 Years Undergoing Major Non-cardiac Surgery

Post-operative delirium (POD) is known to be independently associated with pre-operative frailty, pre-operative cognitive status and per-operative ElectroEncephaloGram (EEG). However, no study has focused on the impact of these pre- and peri-operative outcomes on the prediction of Post-operative delirium (POD). Therefore, this study has been designed to assess the performance …

75 years of age All Phase N/A
V Vanina OLIVERI, Project Manager

Characterization of the Mechanisms of Resistance to Azacitidine

Myelodysplastic syndromes (MDS) are frequent diseases in elderly patients (median age: 71 years). IPSS classification defines low risk (Low and Intermediate 1), and high risk (Intermediate 2 and High) MDS. High-risk MDS (MDS-HR) have a high risk of transformation into acute leukemia with multilineage dysplasia (AML-DML). The success of Azacitidine …

18 years of age All Phase N/A
S Shangyi Liu

Patient-Centered Approach for Treatment Decisions in Mitral Valve Prolapse

This is a qualitative and quantitative study that seeks to obtain information from patients with degenerative mitral valve prolapse and providers regarding factors important in deciding between surgical mitral valve repair (MVR) and transcatheter edge-to-edge repair (TEER). Findings from this study will provide data that can be used to develop …

21 years of age All Phase N/A

Minimally Invasive Treatments of the Thyroid

This is a prospective cohort study to test Minimally Invasive Treatments of the Thyroid (MITT) as potential alternative to surgery in patients with Papillary Thyroid MicroCarcinoma (PTMC)

18 years of age All Phase N/A

Assessing of Artificial Intelligence-based Software Platform for Diabetic Retinopathy Screening

To examine the potential for the detection of diabetic retinopathy (DR) using the artificial intelligence (AI)-based software platform Retina-AI.

18 - 90 years of age All Phase N/A

Simplify language using AI